Literature DB >> 32409309

YAP-Mediated Recruitment of YY1 and EZH2 Represses Transcription of Key Cell-Cycle Regulators.

Sany Hoxha1, Alyssa Shepard1, Scott Troutman1, Huitian Diao2, Joanne R Doherty1, Michalina Janiszewska1, Robert M Witwicki3, Matthew E Pipkin2, William W Ja4, Michael S Kareta5, Joseph L Kissil6.   

Abstract

The Hippo pathway regulates cell proliferation and organ size through control of the transcriptional regulators YAP (yes-associated protein) and TAZ. Upon extracellular stimuli such as cell-cell contact, the pathway negatively regulates YAP through cytoplasmic sequestration. Under conditions of low cell density, YAP is nuclear and associates with enhancer regions and gene promoters. YAP is mainly described as a transcriptional activator of genes involved in cell proliferation and survival. Using a genome-wide approach, we show here that, in addition to its known function as a transcriptional activator, YAP functions as a transcriptional repressor by interacting with the multifunctional transcription factor Yin Yang 1 (YY1) and Polycomb repressive complex member enhancer of zeste homologue 2 (EZH2). YAP colocalized with YY1 and EZH2 on the genome to transcriptionally repress a broad network of genes mediating a host of cellular functions, including repression of the cell-cycle kinase inhibitor p27, whose role is to functionally promote contact inhibition. This work unveils a broad and underappreciated aspect of YAP nuclear function as a transcriptional repressor and highlights how loss of contact inhibition in cancer is mediated in part through YAP repressive function. SIGNIFICANCE: This study provides new insights into YAP as a broad transcriptional repressor of key regulators of the cell cycle, in turn influencing contact inhibition and tumorigenesis. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32409309      PMCID: PMC7299785          DOI: 10.1158/0008-5472.CAN-19-2415

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  49 in total

1.  The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis.

Authors:  Fisun Hamaratoglu; Maria Willecke; Madhuri Kango-Singh; Riitta Nolo; Eric Hyun; Chunyao Tao; Hamed Jafar-Nejad; Georg Halder
Journal:  Nat Cell Biol       Date:  2005-12-11       Impact factor: 28.824

2.  The cyclin-dependent kinase inhibitor p27(Kip1) is a positive regulator of Schwann cell differentiation in vitro.

Authors:  Honghui Li; Huiguang Yang; Yonghua Liu; Weipeng Huan; Shuangwei Zhang; Gang Wu; Qiuhui Lu; Qiuhong Wang; Youhua Wang
Journal:  J Mol Neurosci       Date:  2011-04-12       Impact factor: 3.444

3.  Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ.

Authors:  Minchul Kim; Taekhoon Kim; Randy L Johnson; Dae-Sik Lim
Journal:  Cell Rep       Date:  2015-04-02       Impact factor: 9.423

4.  p27Kip1 expression by contact inhibition as a prognostic index of human glioma.

Authors:  T Fuse; M Tanikawa; M Nakanishi; K Ikeda; T Tada; H Inagaki; K Asai; T Kato; K Yamada
Journal:  J Neurochem       Date:  2000-04       Impact factor: 5.372

Review 5.  Hippo signaling in organ size control.

Authors:  Duojia Pan
Journal:  Genes Dev       Date:  2007-04-15       Impact factor: 11.361

Review 6.  The Salvador-Warts-Hippo pathway - an emerging tumour-suppressor network.

Authors:  Kieran Harvey; Nicolas Tapon
Journal:  Nat Rev Cancer       Date:  2007-03       Impact factor: 60.716

7.  The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis.

Authors:  Kieran F Harvey; Cathie M Pfleger; Iswar K Hariharan
Journal:  Cell       Date:  2003-08-22       Impact factor: 41.582

8.  Contact inhibition and high cell density deactivate the mammalian target of rapamycin pathway, thus suppressing the senescence program.

Authors:  Olga V Leontieva; Zoya N Demidenko; Mikhail V Blagosklonny
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-02       Impact factor: 11.205

9.  Mechanical cue-induced YAP instructs Skp2-dependent cell cycle exit and oncogenic signaling.

Authors:  Wonyul Jang; Tackhoon Kim; Ja Seung Koo; Sang-Kyum Kim; Dae-Sik Lim
Journal:  EMBO J       Date:  2017-07-03       Impact factor: 11.598

10.  NuRD-mediated deacetylation of H3K27 facilitates recruitment of Polycomb Repressive Complex 2 to direct gene repression.

Authors:  Nicola Reynolds; Mali Salmon-Divon; Heidi Dvinge; Antony Hynes-Allen; Gayan Balasooriya; Donna Leaford; Axel Behrens; Paul Bertone; Brian Hendrich
Journal:  EMBO J       Date:  2011-12-02       Impact factor: 11.598

View more
  11 in total

1.  A low amino acid environment promotes cell macropinocytosis through the YY1-FGD6 axis in Ras-mutant pancreatic ductal adenocarcinoma.

Authors:  Yi-Fan Zhang; Qing Li; Pei-Qi Huang; Tong Su; Shu-Heng Jiang; Li-Peng Hu; Xue-Li Zhang; Yue Sun; Hong Pan; Xiao-Mei Yang; Jun Li; Yan-Zhi Gai; Lei Zhu; Lin-Li Yao; Dong-Xue Li; Yong-Wei Sun; Zhi-Gang Zhang; De-Jun Liu; Yan-Li Zhang; Hui-Zhen Nie
Journal:  Oncogene       Date:  2022-01-27       Impact factor: 9.867

2.  Validation of Bromodomain and Extraterminal proteins as therapeutic targets in neurofibromatosis type 2.

Authors:  Joanne Doherty; Vinay Mandati; Maria A González Rodriguez; Scott Troutman; Alyssa Shepard; David Harbaugh; Rachel Brody; Douglas C Miller; Michael S Kareta; Joseph L Kissil
Journal:  Neurooncol Adv       Date:  2022-05-13

3.  P4HA2-induced prolyl hydroxylation suppresses YAP1-mediated prostate cancer cell migration, invasion, and metastasis.

Authors:  Ming Zhu; Ruiqing Peng; Xin Liang; Zhengdao Lan; Ming Tang; Pingping Hou; Jian H Song; Celia Sze Ling Mak; Jiwon Park; Shui-Er Zheng; Ailing Huang; Xingdi Ma; Ruidong Chen; Qing Chang; Christopher J Logothetis; Abhinav K Jain; Sue-Hwa Lin; Hiroyuki Katayama; Samir Hanash; Guocan Wang
Journal:  Oncogene       Date:  2021-09-01       Impact factor: 8.756

4.  The oncogene Mct-1 promotes progression of hepatocellular carcinoma via enhancement of Yap-mediated cell proliferation.

Authors:  Wenjie Yang; Yong Ni; Shikun Yang; Yang Ji; Xinchen Yang; Feng Cheng; Xuehao Wang; Feng Zhang; Jianhua Rao
Journal:  Cell Death Discov       Date:  2021-03-22

Review 5.  Context-dependent transcriptional regulations of YAP/TAZ in stem cell and differentiation.

Authors:  Juan Luo; Peng Li
Journal:  Stem Cell Res Ther       Date:  2022-01-10       Impact factor: 6.832

Review 6.  The long and short non-coding RNAs modulating EZH2 signaling in cancer.

Authors:  Sepideh Mirzaei; Mohammad Hossein Gholami; Kiavash Hushmandi; Farid Hashemi; Amirhossein Zabolian; Israel Canadas; Ali Zarrabi; Noushin Nabavi; Amir Reza Aref; Francesco Crea; Yuzhuo Wang; Milad Ashrafizadeh; Alan Prem Kumar
Journal:  J Hematol Oncol       Date:  2022-03-02       Impact factor: 17.388

Review 7.  A narrative review for the Hippo-YAP pathway in cancer survival and immunity: the Yin-Yang dynamics.

Authors:  Ruochong Wang; Guiquan Zhu
Journal:  Transl Cancer Res       Date:  2022-01       Impact factor: 1.241

Review 8.  Hippo signaling pathway and respiratory diseases.

Authors:  Weifeng Tang; Min Li; Xiaoting Yangzhong; Xifeng Zhang; Anju Zu; Yunjiao Hou; Lin Li; Shibo Sun
Journal:  Cell Death Discov       Date:  2022-04-20

9.  Algorithmic reconstruction of glioblastoma network complexity.

Authors:  Abicumaran Uthamacumaran; Morgan Craig
Journal:  iScience       Date:  2022-03-28

Review 10.  The Hippo Signaling Pathway in Cancer: A Cell Cycle Perspective.

Authors:  Yi Xiao; Jixin Dong
Journal:  Cancers (Basel)       Date:  2021-12-10       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.